Pertussis vaccination in pregnancy in Canada: a cost-utility analysis
B Abu-Raya, D Coyle, JA Bettinger, W Vaudry… - … Open Access Journal, 2020 - cmajopen.ca
Background: The Canadian National Advisory Committee on Immunization recommends
universal vaccination against pertussis in pregnancy. We assessed the cost-effectiveness of …
universal vaccination against pertussis in pregnancy. We assessed the cost-effectiveness of …
[HTML][HTML] Cost-Utility Analysis of Universal Maternal Pertussis Immunisation in Thailand: A Comparison of Two Model Structures
S Botwright, EM Win, N Kapol, S Benjawan… - …, 2023 - Springer
Objectives This study aimed to assess the cost-effectiveness of introducing universal
maternal pertussis immunisation under the national vaccine programme in Thailand …
maternal pertussis immunisation under the national vaccine programme in Thailand …
What pertussis mortality rates make maternal acellular pertussis immunization cost-effective in low-and middle-income countries? a decision analysis
LB Russell, SR Pentakota, CM Toscano… - Clinical Infectious …, 2016 - academic.oup.com
Background Despite longstanding infant vaccination programs in low-and middle-income
countries (LMICs), pertussis continues to cause deaths in the youngest infants. A maternal …
countries (LMICs), pertussis continues to cause deaths in the youngest infants. A maternal …
Cost-effectiveness analysis of pertussis vaccination during pregnancy in Japan
S Hoshi, X Seposo, I Okubo, M Kondo - Vaccine, 2018 - Elsevier
Background Both re-emergence of pertussis outbreak among adolescents/adults and recent
approval of the extended use of DTaP vaccine for boosting adolescents/adults against …
approval of the extended use of DTaP vaccine for boosting adolescents/adults against …
Cost-Effectiveness Analysis of Pertussis Vaccination of Pregnant Women in Norway
JA Shearer - 2019 - duo.uio.no
Norway has one of the highest rates of pertussis in Europe; while this may be due in part to
higher rates of reporting, it is still a serious disease if contracted by infants. Norway's current …
higher rates of reporting, it is still a serious disease if contracted by infants. Norway's current …
Universal Tetanus–Diphtheria–Pertussis Vaccination During Pregnancy: A Cost-Effectiveness Analysis
RC Egan, SR Chaiken, K Derrah, U Doshi… - Obstetrics & …, 2022 - journals.lww.com
OBJECTIVE: To assess the cost effectiveness of tetanus toxoid, reduced diphtheria toxoid,
and acellular pertussis (Tdap) vaccination in pregnant patients in the United States …
and acellular pertussis (Tdap) vaccination in pregnant patients in the United States …
Cost–benefit analysis of hospital based postpartum vaccination with combined tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap)
Y Ding, SH Yeh, CAM Mink, KM Zangwill, NJ Allred… - Vaccine, 2013 - Elsevier
OBJECTIVE: To assess the economic benefits associated with hospital-based postpartum
Tdap (combined tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) …
Tdap (combined tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) …
Cost-effectiveness of maternal immunisation for pertussis in New Zealand
JE Poirrier, B Mungall, IH Lee, A Terlinden… - Value in …, 2014 - valueinhealthjournal.com
Objectives Despite routine vaccination, pertussis remains an important public health
problem with an increase in annual incidences worldwide in recent years. Since infants too …
problem with an increase in annual incidences worldwide in recent years. Since infants too …
Assessing adolescent immunization options for pertussis in Canada: a cost-utility analysis
Background Adolescent tetanus, diphtheria and pertussis (Tdap) immunization helps
prevent pertussis infection. Timing of Tdap receipt represents an important facet of …
prevent pertussis infection. Timing of Tdap receipt represents an important facet of …
Economic impact of the introduction of an acellular pertussis vaccine in Canada: a 6-year analysis
M Iskedjian, G De Serres, TR Einarson, JH Walker - Vaccine, 2010 - Elsevier
BACKGROUND: Between July 1997 and April 1998, Canadian public health agencies
switched from the whole cell vaccine (WCE) to the acellular vaccine (AcE) for pertussis …
switched from the whole cell vaccine (WCE) to the acellular vaccine (AcE) for pertussis …
Related searches
- pregnancy in canada cost utility
- pertussis vaccination cost utility
- pregnancy in canada pertussis vaccination
- pertussis vaccination universal tetanus
- cost effectiveness pregnant women
- cost effectiveness universal tetanus
- postpartum vaccination tetanus toxoid
- cost effectiveness maternal immunisation
- economic evaluation pertussis in china
- decision analysis pertussis immunization
- postpartum vaccination pertussis vaccine
- benefit analysis pertussis vaccine
- postpartum vaccination benefit analysis
- pertussis in canada cost utility
- pertussis vaccination pregnancy in japan
- pertussis immunisation cost utility